Lung contains an inhibitor for nicotinatemononucleotide pyrophosphorylase (carboxylating) of NAD biosynthesis.

This research found that rat, cow, and foal lung extracts contain an inhibitor for nicotinatemononucleotide pyrophosphorylase, a liver enzyme associated with NAD biosynthesis, potentially masking the detection of this enzyme in lung extracts.

Experiment Setup

• The experiment involved studying the lung extract samples provided from rats, cows, and foals (baby horses).
• The primary objective was to investigate the presence of an inhibitor for an important liver enzyme, nicotinatemononucleotide pyrophosphorylase (carboxylating) involved in NAD (Nicotinamide adenine dinucleotide) biosynthesis.

Findings

• The researchers determined that these lung extracts did contain an inhibitor for the aforementioned liver enzyme.
• The inhibitor was found to exhibit certain properties, such as not being dialyzable, being labile (unstable) at a temperature of 100 degrees Celsius, and retention by a 30,000-dalton pore size Amicon membrane. This last point suggests it has a relatively large molecule size.
• When partially purified through a precipitation process involving 40-100% ammonium sulfate, this inhibitor could block the enzyme’s function in a stoichiometric manner (a one-to-one relation).

Implication and Possible Discrepancies

• Lungs are previously not known to contain this specific enzyme or use it to produce NAD de novo (from the beginning).
• The observed inhibitor could potentially conceal the presence of the enzyme in lung extracts and lead to these assumed discrepancies.
• Upon further inspection, a minute quantity of nicotinatemononucleotide pyrophosphorylase-like activity was noted in rat lung samples, but it was absent in cow and foal lungs. This discovery warrants further investigation to completely understand the role and origin of this enzyme in their lung tissues.